Welcome to our dedicated page for Astrana Health news (Ticker: AMEH), a resource for investors and traders seeking the latest updates and insights on Astrana Health stock.
Astrana Health, Inc. (NASDAQ: AMEH), formerly known as Apollo Medical Holdings, Inc., is a leading physician-centric, technology-powered healthcare management company. Based in Alhambra, California, the company leverages proprietary population health management and healthcare delivery platforms to operate an integrated, value-based healthcare model. Astrana Health's mission is to empower medical providers in its network to deliver high-quality, cost-effective care.
The company's extensive network includes primary care physicians, specialists, and hospitalists, catering to patients covered by various insurance plans including Medicare, Medicaid, and private insurance. Astrana Health's services encompass care coordination for patients, families, primary care physicians, specialists, acute care hospitals, and physician groups.
Key Highlights and Achievements:
- Strong Financial Performance: In 2023, Astrana Health reported a significant increase in revenue and net income. For example, total revenue for the second quarter of 2023 was $348.2 million, up 29% from the previous year.
- Strategic Acquisitions and Partnerships: The company has expanded its reach through strategic acquisitions and partnerships. Recent deals include acquiring assets from Texas Independent Providers, forming partnerships with primary care groups in California, and collaborating with IntraCare.
- Environmental, Social, and Governance (ESG) Initiatives: Astrana Health released its inaugural ESG At-a-Glance Report in 2023, highlighting achievements in health equity, community engagement, and environmental responsibility.
- Technological Advancements: The company continues to invest in technology to enhance its healthcare delivery platform, enabling providers to participate in value-based care arrangements and improve patient outcomes.
Ongoing Projects:
- Value-Based Care: Astrana Health remains committed to expanding its value-based care model, focusing on improving patient outcomes and reducing healthcare costs.
- Expansion of Services: The company plans to broaden its healthcare services across multiple states, including California, Nevada, Texas, and beyond.
- Provider Empowerment: Astrana Health continues to focus on empowering its network of providers through training and technology, ensuring they can deliver the best possible care.
For more information, visit www.apollomed.net.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) will release its first-quarter financial results for the period ending March 31, 2023, on May 8, 2023, after market close. A conference call to discuss these results is scheduled for 2:30 p.m. PT / 5:30 p.m. ET on the same day. Investors can dial in to participate or access the call via an online webcast. ApolloMed is a technology-driven healthcare management company focused on value-based care, leveraging proprietary technology to support healthcare providers. The company operates through various subsidiaries including management services organizations and independent practice associations.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH), a leader in value-based healthcare, announced its participation in key investor conferences. The events include the Jefferies Value-Based Healthcare Summit on March 13, 2023, at 11 a.m. PT in Miami Beach, and the Barclays Global Healthcare Conference on March 14, 2023, at 11:35 a.m. PT, also in Miami Beach. Additionally, ApolloMed will present at the Oppenheimer 33rd Annual Healthcare Conference virtually on the same day at 12:20 p.m. PT. The Barclays presentation will be available via live webcast on ApolloMed's website, enhancing its commitment to providing high-quality care through technology-driven solutions.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced its financial results for Q4 and the fiscal year ended December 31, 2022. For the year, total revenue reached $1.14 billion, a 48% increase from 2021. Net income was $49 million, and diluted earnings per share (EPS) stood at $1.08. In Q4 alone, revenue was $294.2 million, up 51%, but the company reported a net loss of $2.6 million. Looking forward, ApolloMed projects 2023 total revenue between $1.3 billion and $1.5 billion, with diluted EPS guidance of $0.95 to $1.20.
Apollo Medical Holdings (NASDAQ: AMEH) announced it will release its financial results for Q4 and the year ended December 31, 2022, on February 23, 2023, after market close. A conference call to discuss these results is scheduled for February 24, 2023, at 5:30 a.m. PT / 8:30 a.m. ET. ApolloMed is positioned as a technology-powered healthcare management company, focusing on enabling providers in value-based care. They utilize proprietary technology solutions to enhance healthcare delivery.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) issued a statement on January 22, 2023, in response to the tragic mass shooting in Monterey Park, California, which resulted in 10 fatalities and several injuries. The leadership, including Dr. Kenneth Sim and the Co-CEOs, expressed their condolences and commitment to support the victims' families and the community. ApolloMed assures that their urgent care centers remain operational to assist the community during this difficult time. They emphasize their long-standing presence and resilience in the Monterey Park area, highlighting a commitment to quality and accessible healthcare.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced its subsidiary APA ACO generated $56.2 million in gross savings for the 2021 performance year, leading to $48.8 million in shared savings from CMS. In 2021, APA ACO's benchmark expenditure was $437.2 million, with actual expenditures of $381.1 million. The company participated in the Next Generation ACO Model, allowing it to take risk for Medicare costs and manage patient populations effectively. This year marked the final year for the Next Generation ACO program, transitioning to the GPDC for 2022.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) will present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 1:30 p.m. PT/4:30 p.m. ET. This participation signifies the company's commitment to engaging with investors and sharing its vision for value-based healthcare. Co-CEO Brandon Sim expressed excitement about being part of the conference and emphasized ApolloMed's goal of enabling high-quality care through technology. The conference runs from January 9-12, 2023, in San Francisco, and the presentation will be available via live webcast.
Apollo Medical Holdings, Inc. (AMEH) announced a new share repurchase program, authorizing the purchase of up to $50 million of its common stock. This program is effective immediately and lacks an expiration date, allowing for flexibility in purchases based on market conditions. The Chief Strategy Officer emphasized that the program reflects the company’s confidence in its growth strategy and aims to support independent healthcare providers. As of September 30, 2022, ApolloMed had a robust cash balance of $184.0 million and 56.7 million shares outstanding.
FAQ
What is the market cap of Astrana Health (AMEH)?
What does Astrana Health, Inc. do?
Where is Astrana Health, Inc. headquartered?
What type of healthcare model does Astrana Health, Inc. operate?
What recent achievements has Astrana Health, Inc. made?
Who does Astrana Health, Inc. cater to?
What are some of Astrana Health, Inc.'s ongoing projects?
What is the significance of the company's recent rebrand to Astrana Health?
How does Astrana Health, Inc. support its network of providers?
What is the focus of Astrana Health, Inc.'s ESG initiatives?
How can I get more information about Astrana Health, Inc.?
